Table 8.

Logistic regression analysis of predictors of favorable renal outcome at 6 months

	B	S.E.	P value	Odds ratio	95% C.I.
Module 1
Baseline eGFR	.010	.011	.377	1.010	.988	1.031
Gender (male)	.044	.494	.929	1.045	.396	2.753
Age	.023	.020	.249	1.023	0.984	1.063
NGAL	.001	.001	.152	1.001	1.000	1.003
Urine cf-mtDNA	.596	.266	.025*	1.815	1.076	3.059
Constant	−2.543	1.632	.119	.079
Module 2
Baseline eGFR	.027	.014	.061	1.027	.999	1.056
Gender (male)	.278	.587	.636	1.320	.417	4.175
Age	.054	.024	.027*	1.056	1.006	1.107
NGAL	.002	.001	.110	1.002	1.000	1.004
Urine cf-nDNA	.255	.102	.012*	1.290	1.057	1.575
Constant	−5.688	2.182	.009	.003

*P < 0.05. Module 1: test urine cf-mtDNA as a covariate; Module 2: test urine cf-nDNA as a covariate

NGAL, neutrophil gelatinase-associated lipocalin (ng/mL); cf-mtDNA, cell-free mitochondrial DNA (GE/mL); cf-nDNA, cell-free nuclear DNA (GE/mL); GE/mL, genome equivalents/mL